Weight Management
Overweight and obesity management can include behavioural, nutritional and physical-activity support, and medicine for some people; which medicine, if any, is a decision to reach with a prescriber. This group holds two medicines used for weight, two diabetes medicines with no weight indication here, and two respiratory medicines with no connection to either.
Clenbuterol Tablets
40mcg
Utilised to manage bronchospastic conditions to alleviate breathing restrictions and support metabolic temperature parameters.
Key points
- NICE’s guidance on overweight and obesity management sets out assessment of weight-related health before any treatment is chosen.
- Medicine use forms part of a longer-term, reviewed plan rather than working as a standalone treatment.
- Two of the six medicines here are used for diabetes or breathing conditions rather than for weight.
Medicines used for weight management
Xenical contains orlistat and is used for obesity management. Mysimba combines naltrexone with bupropion and is used for chronic weight management. Both are taken as tablets.
Diabetes medicines with no weight indication here
Rybelsus contains semaglutide and Victoza contains liraglutide; both are used for type 2 diabetes mellitus rather than for weight. Rybelsus is a tablet and Victoza is given by auto-injector.
Respiratory medicines with no weight connection
Clenbuterol Tablets contain clenbuterol and Asthalin contains salbutamol; both are used for bronchospasm, and Asthalin is also used for asthma and COPD. Neither has a use here connected to weight at all.